First MRNA COVID Vaccine Given Nod For Phase 2/3 Trials In India
[email protected]25 Oct, 2021News
The Drug Controller General of India has approved the Phase 2 and 3 clinical trials of India's first Covid-19 mRNA vaccine. Pune-based pharma major Gennova Biopharmaceuticals Ltd is developing the nation's first mRNA-based Covid-19 vaccine. It is among a few pharmaceutical firms worldwide, including Moderna Inc and Pfizer Inc, to use mRNA technology in its coronavirus shot.
Related Bookmarks
- India�s First MRNA Covid-19 Vaccine Gets Approval For Phase II And III Trials By Centre
- DCGI Finds First MRNA Vaccine Safe, Gives Nods For Phase 2/3 Trials
- Healthy Floor Makes A Healthy Home
- agence de voyage qui s'occupe des visas
- Why Is Hulu Not Loading on Chrome?
- Best Gutter Cleaning Services to Contact in Esher
- How to Add Social Media Feed to Website
- 4 Things Every Hotel Needs To Consider Before Finalizing With A Hotel Supplier
- UPS Maintenance Tips You Must Know
- How to Change the Email Address on Instagram?
Recent Profiles
Arya Rose
Three Peaks International
Bolsterbiz Llp
Sunwin
World Tribe Tours
Femme Moderne Center For Aesthetics
Jryn Eye Clinic
Turtle Electric, Llc
Joy George
Go88